Combination Therapy for Methicillin-resistant Staphylococcus aureus (MRSA) Bacteremia: Beauty Remains in the Eye of the Beholder
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Combination Therapy for Methicillin-resistant Staphylococcus aureus (MRSA) Bacteremia: Beauty Remains in the Eye of the Beholder
Authors
Keywords
-
Journal
CLINICAL INFECTIOUS DISEASES
Volume -, Issue -, Pages -
Publisher
Oxford University Press (OUP)
Online
2020-09-02
DOI
10.1093/cid/ciaa1326
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effect of Vancomycin or Daptomycin With vs Without an Antistaphylococcal β-Lactam on Mortality, Bacteremia, Relapse, or Treatment Failure in Patients With MRSA Bacteremia
- (2020) Steven Y. C. Tong et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Clinical Data on Daptomycin Plus Ceftaroline Versus Standard of Care Monotherapy in the Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia
- (2019) Matthew Geriak et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Daptomycin plus beta-lactam combination therapy for methicillin-resistant Staphylococcus aureus bloodstream infections: a retrospective, comparative cohort study
- (2019) Sarah C J Jorgensen et al. CLINICAL INFECTIOUS DISEASES
- Is Daptomycin plus Ceftaroline Associated with Better Clinical Outcomes than Standard of Care Monotherapy for Staphylococcus aureus Bacteremia?
- (2019) Andre C. Kalil et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The Combination of Daptomycin and Fosfomycin Has Synergistic, Potent, and Rapid Bactericidal Activity against Methicillin-Resistant Staphylococcus aureus in a Rabbit Model of Experimental Endocarditis
- (2018) Cristina García-de-la-Mària et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Adjunctive rifampicin for Staphylococcus aureus bacteraemia (ARREST): a multicentre, randomised, double-blind, placebo-controlled trial
- (2018) Guy E Thwaites et al. LANCET
- OUP accepted manuscript
- (2018) CLINICAL INFECTIOUS DISEASES
- Staphylococcus aureus bacteraemia and endocarditis – epidemiology and outcome: a review
- (2017) Hilmir Asgeirsson et al. Infectious Diseases
- Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management
- (2015) Steven Y. C. Tong et al. CLINICAL MICROBIOLOGY REVIEWS
- Staphylococcus aureus Bloodstream Infection and Endocarditis - A Prospective Cohort Study
- (2015) Vincent Le Moing et al. PLoS One
- Combination Antibiotic Treatment of Serious Methicillin-Resistant Staphylococcus aureus Infections
- (2015) S. Hal et al. SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE
- Staphylococcus aureus bloodstream infection: A pooled analysis of five prospective, observational studies
- (2013) Achim J. Kaasch et al. JOURNAL OF INFECTION
- Nafcillin enhances innate immune-mediated killing of methicillin-resistant Staphylococcus aureus
- (2013) George Sakoulas et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Predictors of Mortality in Staphylococcus aureus Bacteremia
- (2012) S. J. van Hal et al. CLINICAL MICROBIOLOGY REVIEWS
- Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children
- (2011) Catherine Liu et al. CLINICAL INFECTIOUS DISEASES
- Initial Low‐Dose Gentamicin forStaphylococcus aureusBacteremia and Endocarditis Is Nephrotoxic
- (2009) Sara E. Cosgrove et al. CLINICAL INFECTIOUS DISEASES
- Mortality of S. aureus bacteremia and infectious diseases specialist consultation – A study of 521 patients in Germany
- (2009) Siegbert Rieg et al. JOURNAL OF INFECTION
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started